期刊文献+

Proteome analysis of hepatic non-parenchymal cells of immune liver fibrosis rats 被引量:5

Proteome analysis of hepatic non-parenchymal cells of immune liver fibrosis rats
暂未订购
导出
摘要 Elucidation of the mechanisms of liver fibrogenesis is important to treat liver fibrosis.In this study,we established rat models of liver fibrosis with stages from 0–1,2,and 3–4 to 4 at 2,4,6,and 8 weeks,respectively,by injection of pig serum.Liver fibrogenesis was detected by Masson’s trichrome staining.Rat non-parenchymal cells(NPCs)were enriched 4-fold by Percoll density gradient centrifugation.Protein extracts from NPCs were prepared at 4 and 8 weeks,separated by two-dimensional electrophoresis,and then stained with Coomassie Blue G-250.At 4 weeks,we identified 18 non-redundant differentially expressed proteins of which protein disulfide-isomerase associated protein 3(PDIA3)and NDUV showed consistent expression at protein and mRNA levels from 4 to 8 weeks.PDIA3 was found to be down-regulated by Western blotting in the rat model and immunohistochemically in human liver.Our results revealed important aspects of the pathogenesis/progression of liver fibrosis and demonstrated important changes in protein expression levels of NPCs at various stages of liver fibrosis. Elucidation of the mechanisms of liver fibrogenesis is important to treat liver fibrosis. In this study, we established rat models of liver fibrosis with stages from 0-1, 2, and 3-4 to 4 at 2, 4, 6, and 8 weeks, respectively, by injection of pig serum. Liver fi- brogenesis was detected by Masson's trichrome staining. Rat non-parenchymal cells (NPCs) were enriched 4-fold by Percoll density gradient centrifugation. Protein extracts from NPCs were prepared at 4 and 8 weeks, separated by two-dimensional electrophoresis, and then stained with Coomassie Blue G-250. At 4 weeks, we identified 18 non-redundant differentially ex- pressed proteins of which protein disulfide-isomerase associated protein 3 (PDIA3) and NDUV showed consistent expression at protein and mRNA levels from 4 to 8 weeks. PDIA3 was found to be down-regulated by Western blotting in the rat model and immunohistochemically in human liver. Our results revealed important aspects of the pathogenesis/progression of liver fi- brosis and demonstrated important changes in protein expression levels of NPCs at various stages of liver fibrosis.
出处 《Science China(Life Sciences)》 SCIE CAS 2014年第3期303-314,1-5,共12页 中国科学(生命科学英文版)
基金 supported by the Major New Drug Discovery Science and Technology(2012ZX09303013) the National Basic Research Program of China(2011CB910700) National Natural Science Foundation of China(81271834) China Postdoctoral Science Foundation(20100471238) China Postdoctoral Science Special Foundation(201104516) National Key Technology R&D Program of China(2012ZX10001003) the Postdoctoral Science Foundation of Central South University,Science and Technology Commission of Shanghai Municipality(11DZ2292900)
关键词 liver fibrosis PROTEOMICS non-parenchymal cells protein disulfide-isomerase associated protein 3 蛋白质组分 肝纤维化 大鼠肝 细胞 免疫性 Percoll 密度梯度离心 二硫键异构酶
  • 相关文献

参考文献34

  • 1Yuen MF, Hou JL, Chutaputti A. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol, 2009, 24: 346-353.
  • 2Shen LP, Zhang Y, Wang F, Zhang S, Yang JY, Fang KX, Yu T, Wang XY, Zhang WY, Bi SL. Epidemiological changes in hepatitis B prevalence in an entire population after 20 years of the universal HBV vaccination programme. Epidemiol Infect, 139: 1159-1165.
  • 3Knolle PA, Gerken G. Local control of the immune response in the liver. Immunol Rev, 2000, 174: 21-34.
  • 4Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice. J Immunol, 2002, 169: 5188-5195.
  • 5Ramadori G, Moriconi F, Malik I, Dudas J. Physiology and pathophysiology of liver inflammation, damage and repair. J Physiol Pharmacol, 2008, 59(Suppl 1): 107-117.
  • 6Wu J, Meng Z, Jiang M, Pei R, Trippler M, Broering R, Bucchi A, Sowa JP, Dittmer U, Yang D, Roggendorf M, Gerken G, Lu M, Schlaak JF. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology, 2009, 49: 1132-1140.
  • 7Baba Y, Uetsuka K, Nakayama H, Dot K. Rat strain differences in the early stage of porcine-serum-induced hepatic fibrosis. Exp Toxicol Pathol, 2004, 55: 325-330.
  • 8Tsukamoto H, Matsuoka M, French SW. Experimental models of hepatic fibrosis: a review. Semin Liver Dis, 1990, 10: 56-65.
  • 9Schuppan D, Ruehl M, Somasundaram R, Hahn EG. Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis, 2001, 21: 351-372.
  • 10Fujisawa G, Muto S, Okada K, Kusano E, Ishibashi S. Mineralocorticoid receptor antagonist spironolactone prevents pig serum-induced hepatic fibrosis in rats. Transl Res, 2006, 148: 149-156.

同被引文献27

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部